Loading organizations...
Taysha Gene Therapies has raised $275.0M across 4 funding rounds.
Taysha Gene Therapies has raised $275.0M in total across 4 funding rounds.
Taysha Gene Therapies has raised $275.0M across 4 funding rounds. Most recently, it raised $50.0M Other Equity in October 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 24, 2022 | $50M Venture Round | Naoki Okamura | — | Announced |
| Aug 16, 2021 | $100M Debt Financing | Silicon Valley Bank | — | Announced |
| Aug 5, 2020 | $95M Series B | Fidelity Management & Research Company | ArrowMark Partners, BlackRock, Casdin Capital, Franklin Templeton, GV, Invus, Octagon Capital, PBM Capital, Perceptive Advisors, Sands Capital, Venrock | Announced |
| Apr 29, 2020 | $30M Seed | Sean Nolan, Paul Manning | — | Announced |
Taysha Gene Therapies has raised $275.0M in total across 4 funding rounds.
Taysha Gene Therapies's investors include Naoki Okamura, Silicon Valley Bank, Fidelity Management & Research Company, ArrowMark Partners, BlackRock, Casdin Capital, Franklin Templeton, Google Ventures, Invus, Octagon Capital, PBM Capital, Perceptive Advisors.
